Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Johan Ingvarsson"'
Autor:
Britta Wahren, Johan Ingvarsson, Carsten Peterson, Morten Krogh, Gunnel Engström, Anders Carlsson, Carl A.K. Borrebaeck, Peter Ellmark, Christer Wingren, Ulrika Harmenberg
Publikováno v:
PROTEOMICS. 8:2211-2219
The driving force behind oncoproteomics is to identify protein signatures that are associated with a particular malignancy. Here, we have used a recombinant scFv antibody microarray in an attempt to classify sera derived from pancreatic adenocarcinom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc656708bc436502af5951e8e159946e
https://doi.org/10.1002/pmic.200701167
https://doi.org/10.1002/pmic.200701167
Autor:
Carl A.K. Borrebaeck, Johan Ingvarsson, Anders Carlsson, Bo Baldertorp, Håkan Olsson, Mårten Fernö, Christer Wingren, Peter Ellmark
Publikováno v:
European Journal of Cancer. 44:472-480
The driving force behind oncoproteomics is to identify biomarker signatures associated with a particular malignancy. Here, we have for the first time used large-scale recombinant scFv antibody microarrays in an attempt to classify metastatic breast c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a34885430e511cf9bfe544fd587b1b3f
https://doi.org/10.1016/j.ejca.2007.11.025
https://doi.org/10.1016/j.ejca.2007.11.025
Autor:
Gunnar Skagerberg, Christer Wingren, Johan Ingvarsson, Anders Carlsson, Oscar Persson, Leif G. Salford, Peter Siesjö, Edward Visse, Linda Geironson Ulfsson, Carl A.K. Borrebaeck
Publikováno v:
Neuro-Oncology. 9:467-602
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d83ea6cf255106c1bd995328acb3c51
https://doi.org/10.1215/15228517-2007-039
https://doi.org/10.1215/15228517-2007-039
Publikováno v:
PROTEOMICS. 7:3055-3065
Antibody-based microarray is a novel technology with great potential within high-throughput proteomics. The process of designing high-performing antibody (protein) microarrays has, however, turned out to be a challenging process. In this study, we ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b80c918cc9f245bb8dca18a0bd7b421f
https://doi.org/10.1002/pmic.200700025
https://doi.org/10.1002/pmic.200700025
Autor:
Anders G. Sjöholm, Carl A.K. Borrebaeck, Bo Jansson, Anette Larsson, Christer Wingren, Johan Ingvarsson, Lennart Truedsson
Publikováno v:
Journal of Proteome Research. 6:3527-3536
Antibody-based microarrays is a novel technology with great promise for high-throughput proteomics. The process of designing high-performing arrays has, however, turned out to be challenging. Here, we have designed the next generation of a human reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb2edb16afcb871a49f5b3d1b1cc2e0a
https://doi.org/10.1021/pr070204f
https://doi.org/10.1021/pr070204f
Autor:
Carl A.K. Borrebaeck, Anders Carlsson, B. Samuel Lundin, Peter Ellmark, Johan Ingvarsson, Christer Wingren
Publikováno v:
Molecular & Cellular Proteomics. 5:1638-1646
Antibody microarray based technology is a powerful emerging tool in proteomics, target discovery, and differential analysis. Here, we report the first study where recombinant antibody fragments have been used to construct large scale antibody microar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::845c6a6854b81db9de86610fb479d6e6
https://doi.org/10.1074/mcp.m600170-mcp200
https://doi.org/10.1074/mcp.m600170-mcp200
Autor:
Anders A. Bengtsson, Anders Carlsson, Carl A.K. Borrebaeck, Johan Ingvarsson, Gunnar Sturfelt, Dirk M. Wuttge, Christer Wingren
Publikováno v:
Molecular & Cellular Proteomics : MCP
Systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) are two severe autoimmune connective tissue diseases. The fundamental knowledge about their etiology is limited and the conditions display complex pathogenesis, multifaceted presentation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a287d68af69cafa33b79a9cf9a27783e
http://europepmc.org/articles/PMC3098590
http://europepmc.org/articles/PMC3098590
Autor:
Carl A.K. Borrebaeck, Anders Carlsson, Christer Wingren, Leif G. Salford, Johan Ingvarsson, Bengt Widegren, Oscar Persson
Publikováno v:
Proteomics. Clinical applications. 4(6-7)
Purpose: Glioblastoma multiforme (GBM) is a frequent and aggressive type of primary brain tumor with a heterogeneous origin. GBM is highly therapy resistant and carries a dismal prognosis for the patient. The purpose of this discovery study was to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::718f2429344e9d672d3d0d3319507a60
https://pubmed.ncbi.nlm.nih.gov/21137077
https://pubmed.ncbi.nlm.nih.gov/21137077
Publikováno v:
Journal of proteome research. 7(1)
Generating proteomic maps of membrane proteins, common targets for therapeutic interventions and disease diagnostics, has turned out to be a major challenge. Antibody-based microarrays are among the novel rapidly evolving proteomic technologies that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4331f39dbee747d2fb7750d13ebd5889
https://pubmed.ncbi.nlm.nih.gov/18047267
https://pubmed.ncbi.nlm.nih.gov/18047267
Publikováno v:
Journal of proteome research. 5(1)
Antibody-based microarray is a novel technology with great promise within high-throughput proteomics. The tremendous complexity of all proteomes will, however, pose major technological challenges, especially when targeting low-abundant analytes that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f14137305170b0e7a774e362bc13a01f
https://pubmed.ncbi.nlm.nih.gov/16396508
https://pubmed.ncbi.nlm.nih.gov/16396508